Abiopharma

News list

TABUTEAU HERRIOT 🟢 acquired 24.1K shares (1 derivative) of Axsome Therapeutics, Inc. (AXSM) Transaction Date: Apr 21, 2026 | Filing ID: 174417

Full text

News bot April 24, 2026, 1:02 a.m.
🔍 TABUTEAU HERRIOT (Executive)

Company: Axsome Therapeutics, Inc. (AXSM)

Report Date: 2026-04-21
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 24,081
Detailed Transactions and Holdings:
- Acquired 24,081 shares of Performance Stock Units (Derivative)
  Date: 2026-04-21 | Code: A | equity_swap_involved: false | shares_owned_after: 24,081.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2: Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.